SCHEMBL16097729

SCHEMBL16097729

O=C1CCCN1c1nc(Cl)ncc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.39
SIGMAR1 Q99720 1/20 0.37
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RPS6KA5 O75582 2/20 0.35
RPS6KA4 O75676 1/20 0.35
PIM1 P11309 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
AKR1C3 P42330 1/20 0.34
HTR6 P50406 1/20 0.34
HSD17B10 Q99714 1/20 0.33
RET P07949 1/20 0.33
MAPT P10636 1/20 0.33
ALOX5AP P20292 1/20 0.33
MET P08581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16097815 0.84 SMN1; SMN2 (0.50) CNR2L3MBTL1SIGMAR1SMN1; SMN2RPS6KA5
SCHEMBL23331023 0.77 HSD17B10 (0.40) CNR2L3MBTL1MAPK8MAPK9MAPK10
SCHEMBL31093334 0.76 ALDH1A1 (0.46) CNR2L3MBTL1ALDH1A1AKR1C3HTR6
SCHEMBL22858415 0.75 MAPK8 (0.49) CNR2MAPK8MAPK9MAPK10PIM1
SCHEMBL30919743 0.75 ROCK1 (0.49) L3MBTL1SMN1; SMN2ALDH1A1HSD17B10MAPT
SCHEMBL23330864 0.73 CNR2 (0.36) CNR2L3MBTL1ALDH1A1HTR6HSD17B10
SCHEMBL19192016 0.73 IDH1 (0.38) SMN1; SMN2RPS6KA5RPS6KA4ABL1BCR
SCHEMBL24759988 0.73 CNR2 (0.41) CNR2L3MBTL1SIGMAR1MAPK8MAPK9
SCHEMBL27258203 0.72 MAPK8 (0.47) MAPK8MAPK9MAPK10METROS1
SCHEMBL25197838 0.72 CNR2 (0.40) CNR2L3MBTL1SIGMAR1SMN1; SMN2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014147586-A1 1-(2-(ETHYLAMINO)PYRIMIDIN-4-YL)PYRROLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH NOVARTIS AG (CH) 2014-09-25 WO disclosed